Eyeworld

EW MEETING REPORTER 91 serted. Only one subject had an ex- change for dysphotopsia. "Refractive lens exchange re- mains an off-label procedure," he said. "These patients are extraordi- narily happy, despite the relatively high price tag of the procedure. As we've gone to newer technology, the outcomes have improved. I believe that RLE is the foundation of future refractive surgery." Cataract surgery to reduce IOP Richard Lindstrom, M.D., adjunct professor emeritus, department of ophthalmology, University of Min- nesota, and founder, Minnesota Eye Consultants, Minneapolis, revisited his argument for performing cataract surgery to reduce IOP in glaucoma patients who have an elevated pres- sure reading of 21-25 mm Hg. "The easiest glaucoma operations are in the pseudophakic patient with a vir- gin conjunctiva," he said. Until de- vices are developed that can safely lower IOP with minimal risk of com- plications, Dr. Lindstrom said cataract surgery alone can do the job and lower IOP. Benefits of accommodating IOLs John A. Hovanesian, M.D., Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, touted the benefits of accommodating IOLs in his talk and introduced new tech- nologies coming down the pipe. The Crystalens AO (Bausch & Lomb) is available in the U.S. and gives 1.5 D of accommodation in more than 80% of patients. Other implants that are not yet approved but which sur- geons are keeping their eyes on in- clude the dual-optic Synchrony (AMO), the Tetraflex (Lenstec, St. Pe- tersburg, Fla.), the NuLens (Tel Aviv), the FluidVision (PowerVision, Bel- mont, Calif.), and the 1CU (Hu- manOptics, Erlangen, Germany)."Presbyopia-correcting im- plants are slowly becoming the new standard of care in cataract surgery," Dr. Hovanesian said. "Start working with them now so you're part of the future of eyecare." Square-edge optics Jack Holladay, M.D., Houston, Texas, explained the impact of square-edge optics on transmitted light rays. Negative dysphotopsia is the shadow or "umbra" created by the non-refracted and refracted rays incident on the functioning retina. The space can be eliminated by flip- ping the optic or piggybacking the IOL, allowing time for the temporal capsule to become translucent, Dr. Holladay said. Editors' note: Dr. Holladay has financial interests with AMO and AcuFocus (Irvine, Calif.). Dr. Hovanesian has fi- nancial interests with AMO, Allergan, and Bausch & Lomb. Dr. Lindstrom has financial interests with AMO, Alcon, and Bausch & Lomb, among others. Dr. Packer has financial interests with AMO, Bausch & Lomb, Carl Zeiss Meditec (Dublin, Calif.), and WaveTec (Aliso Viejo, Calif.). 7-140-*-2( Tap into the incredible network of the The American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators with the ASCRS ASOA Ophthalmic Buyers Guide. Powered by MultiView, the Guide gives professionals a faster and easier way to ènd industry resources and suppliers. Simpliènd your search today at www.ascrs.org or www.asoa.org continued on page 92 February 2011

• Cover